Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretomanid with Rifampin or Rifabutin for Drug-Sensitive TB
NCT02256696Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2015
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 2 trial of pretomanid in pulmonary tuberculosis (TB), sponsored by Johns Hopkins University. Started Apr 2015; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02256696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256696.